URSO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 360
AS - Asia 231
EU - Europa 206
SA - Sud America 8
OC - Oceania 4
AF - Africa 2
Totale 811
Nazione #
US - Stati Uniti d'America 360
IT - Italia 131
SG - Singapore 124
CN - Cina 45
DE - Germania 24
FI - Finlandia 22
ID - Indonesia 18
IN - India 14
VN - Vietnam 12
GB - Regno Unito 10
SE - Svezia 7
HK - Hong Kong 6
CZ - Repubblica Ceca 5
IR - Iran 5
AU - Australia 4
BR - Brasile 4
KR - Corea 4
AR - Argentina 2
BE - Belgio 2
CO - Colombia 2
EG - Egitto 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
Totale 811
Città #
Singapore 84
Chandler 60
Shanghai 35
New York 30
Ashburn 25
Milan 23
Ferrara 21
Fairfield 18
Jakarta 18
Helsinki 14
Bologna 13
Dong Ket 12
Los Angeles 12
Munich 11
Houston 10
Boardman 8
Lappeenranta 8
Santa Clara 8
Wilmington 7
Cambridge 6
Ferrara di Monte Baldo 6
Hong Kong 6
Princeton 6
Bremen 5
Brno 5
Parma 5
Poggio Renatico 5
San Diego 5
Woodbridge 5
Rovigo 4
Seattle 4
Sydney 4
Addison 3
Ann Arbor 3
Chicago 3
Copparo 3
Florence 3
Frankfurt am Main 3
Hounslow 3
Isfahan 3
Kochi 3
London 3
Alpharetta 2
Brasília 2
Cairo 2
Chandigarh 2
Cipolletti 2
Dej 2
Forlì 2
Incheon 2
Istanbul 2
Maglie 2
Medellín 2
Molfetta 2
Occhiobello 2
Padova 2
Pelotas 2
Reggio Emilia 2
Sandston 2
Turnhout 2
Agrate Conturbia 1
Alzano Lombardo 1
Amsterdam 1
Atlanta 1
Bhubaneswar 1
Cheongju-si 1
Delhi 1
Falls Church 1
Indore 1
Kilburn 1
Leawood 1
Lisbon 1
New Bedfont 1
Pavia 1
Portomaggiore 1
Southwark 1
Stienta 1
Tehran 1
Tokyo 1
Vienna 1
Washington 1
Totale 570
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 91
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 58
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 47
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 43
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 38
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 33
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 32
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 30
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 30
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 26
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 26
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 25
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 25
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 21
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 20
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 19
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 18
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 18
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 17
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 17
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 16
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 14
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 14
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 13
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 13
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 12
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 12
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 12
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 12
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 12
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 11
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 11
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 10
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 9
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 9
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 9
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 8
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 8
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 8
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 8
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 8
Clinical applications of long axial field-of-view PET/CT scanners in oncology 8
Molecular imaging of PARP in cancer: state-of-the-art 8
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 7
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 7
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 6
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 5
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 5
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 4
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 4
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 4
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 4
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 4
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 3
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 3
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 3
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 3
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 3
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 3
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 3
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 2
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 2
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 1
Is There a Role for FAPI PET in Urological Cancers? 1
Totale 956
Categoria #
all - tutte 9.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 1 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/2025275 74 87 114 0 0 0 0 0 0 0 0 0
Totale 956